Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Struggling Telesta Cuts Another 30% of Workforce

Telesta Therapeutics will terminate its bladder cancer drug MCNA project, shutter its Montreal-based manufacturing facility and terminate another 30 percent of its workforce.

Read More »

Another Round of Layoffs for Pfizer in New York

As Pfizer winds down its vaccine production at its Pearl River site, Pfizer has plans to lay off an additional 151 employees – completing a process that began in 2010 when the company opted to phase out vaccine production at the site.

Read More »

Virtus Pharmaceuticals Inc. Announces Launch of Prometrium (Progesterone, USP Capsules)

Virtus Pharmaceuticals Inc. – a specialty niche pharmaceutical company and part of the Linden Capital Partners portfolio – announced it launched Prometrium (Progesterone, USP Capsules), the company’s first branded product.

Read More »

Biogen exercises option to develop muscle drug after trial success

Biogen Inc. said it would exercise an option to develop and commercialize an experimental genetic muscle-disorder drug after an interim analysis of late-stage data showed patients experienced statistically significant improvement.

Read More »

Keryx withdraws 2016 forecast on renal drug supply disruption

Keryx Biopharmaceuticals Inc. withdrew its full-year 2016 forecast due to a disruption in production of its only approved drug, Auryxia.

Read More »

Pfizer acquires Bamboo Therapeutics

Pfizer acquired privately held gene therapy developer Bamboo Therapeutics in a deal worth up to $645 million to boost its presence in the treatment of rare diseases.

Read More »

Pharma and tech converge in ‘fantastic voyage’ to fight disease

The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware.

Read More »

Celgene Accused of ‘Scheme to Gain Billions’

Allegations were made that Celgene donated millions of dollars to charities that help patients afford high-priced cancer drugs as part of a profit-making scheme.

Read More »

GSK and Verily forge bioelectronic medicines firm

GSK and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom